Arizona Oncology, one of the largest medical groups in Arizona devoted exclusively to cancer care and a practice in The US Oncology Network, welcomes four additional gynecologic oncologists to the practice.
This exciting expansion will enhance its gynecologic oncology program, offering the largest, most comprehensive state-of-the-art gynecologic oncology program in the region. The four new physicians are: Dana M. Chase, M.D., F.A.C.O.G., Heather J. Dalton, M.D., Bradley J. Monk, M.D., F.A.C.O.G., F.A.C.S., and Lyndsay J. Willmott, M.D., F.A.C.O.G. All are highly-skilled and credentialed with extensive experience providing specialized services to women with gynecologic cancers.
“We are excited to have these four highly-regarded and knowledgeable physicians join our practice,” said Shana Wingo, M.D., a gynecologic oncologist with Arizona Oncology. “We are committed to finding physicians who share our patient care philosophy, treatment goals, and work ethic. We also admire those who give back to the community they serve. These like-minded physicians are a perfect fit and will greatly enhance our program, allowing us to better serve women throughout our region who need specialized gynecologic care.”
The new physicians will be joining Arizona Oncology’s highly-skilled and experienced team of gynecologic specialists who serve the greater Phoenix and northern Arizona region: Drs. Snehal Bhoola, Matthew Borst, Mike Janicek, Dennis Scribner, and Shana Wingo. Four other Arizona Oncology gynecologic oncologists treat patients in the Tucson area: Drs. Michael Bookman, Joseph Buscema, Alton Hallum III and Candice Lewis. These world-class physicians have dedicated their entire professional lives to meeting the unique needs of women fighting female cancers, and each has years of experience solely focused on these unique diseases. All Arizona Oncology gynecologic oncologists―including the four new physicians―have in-depth training and deep experience in the very latest treatment advancements, including minimally invasive laparoscopic surgery and the da Vinci® robotic-assisted Surgical System.
The practice’s gynecologic oncology team performs the most minimally invasive da Vinci robotic-assisted cancer surgeries in Arizona and has the most expertise in women’s health in the state.
The program serves as a regional resource for patients and physicians and is well respected throughout the medical community for its specialized treatment capabilities for gynecologic cancers. It offers evidence-based treatment plans, personalized chemotherapy, research and clinical trials, genetic and molecular profiling of tumors, minimally invasive surgical procedures, as well as complex pelvic surgery performed by some of the nation’s leading gynecologic oncologists.
Not only is Arizona Oncology a leader in gynecologic oncology, it is also a leading provider of comprehensive cancer care in the state. It is the largest cancer practice in Arizona with more than 75 physicians and is among the biggest medical groups in the state. In addition to gynecologic oncology, the practice provides integrated multidisciplinary cancer care, including medical and radiation oncology, urology, stem cell transplantation and an extensive array of supportive care services to help patients and their loved ones have the best possible experience and outcome. Also, as a practice in The US Oncology Network, Arizona Oncology gains access to comprehensive practice management capabilities and value-based care expertise, both critical for large practices navigating today’s challenging healthcare landscape. The Network is supported by McKesson Specialty Health, an industry leader in solutions that empower the community patient care delivery system to advance the science, technology and quality of care.
The new physicians will treat patients in Arizona Oncology facilities in East Valley, Deer Valley,
Scottsdale and the Phoenix Biltmore Cancer Center. With the expanded physician staff, the practice can now give more patients convenient access to high-level surgeons and specially trained surgical care teams who will provide advanced procedures in state-of-the-art facilities. Additionally, they can also offer more patients the opportunity to participate in leading-edge clinical trials in their local community where they have the support of family and friends.
“With our larger expanded group collaborating to serve our patients, we will affect positive change in more women’s lives,” noted Dr. Wingo. “When trying to find better ways to treat women, the more patients we serve, the better data we can collect. This leads to high-quality clinical research that can advance the care of women battling gynecologic cancers.”
